Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Stanulla

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Experimental Medicine|October 2, 2013
Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemiaLena Harder, Georg Eschenburg, Antonia Zech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNSGunnar Cario, Shai Izraeli, Anja Teichert, et al.
Genes, Chromosomes & Cancer|March 6, 2003
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposidesThorsten Langer, Markus Metzler, Dirk Reinhardt, et al.
Cancers|February 25, 2022
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer PatientsNurul Khalida Ibrahim, Ahmed Eraky, Jan Eggers, et al.
Cold Spring Harbor Molecular Case Studies|July 7, 2017
Metastatic triple-negative breast cancer patient with <i>TP53</i> tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse eventsTobias Meißner, Adam Mark, Casey Williams, et al.
Blood|May 8, 2013
Leukemia surfaceome analysis reveals new disease-associated featuresPaulina Mirkowska, Andreas Hofmann, Lukasz Sedek, et al.
Blood Advances|October 7, 2020
TNFR2 is required for RIP1-dependent cell death in human leukemiaJúlia Aguadé-Gorgorió, Scott McComb, Cornelia Eckert, et al.
Blood Advances|January 14, 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALLTamara Kempter, Paulina Richter-Pechańska, Katarzyna Michel, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.
Hemasphere|July 20, 2023
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic LeukemiaDanielle Brandes, Layal Yasin, Karin Nebral, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Experimental Medicine|October 2, 2013
Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemiaLena Harder, Georg Eschenburg, Antonia Zech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNSGunnar Cario, Shai Izraeli, Anja Teichert, et al.
Genes, Chromosomes & Cancer|March 6, 2003
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposidesThorsten Langer, Markus Metzler, Dirk Reinhardt, et al.
Cancers|February 25, 2022
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer PatientsNurul Khalida Ibrahim, Ahmed Eraky, Jan Eggers, et al.
Cold Spring Harbor Molecular Case Studies|July 7, 2017
Metastatic triple-negative breast cancer patient with <i>TP53</i> tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse eventsTobias Meißner, Adam Mark, Casey Williams, et al.
Blood|May 8, 2013
Leukemia surfaceome analysis reveals new disease-associated featuresPaulina Mirkowska, Andreas Hofmann, Lukasz Sedek, et al.
Blood Advances|October 7, 2020
TNFR2 is required for RIP1-dependent cell death in human leukemiaJúlia Aguadé-Gorgorió, Scott McComb, Cornelia Eckert, et al.
Blood Advances|January 14, 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALLTamara Kempter, Paulina Richter-Pechańska, Katarzyna Michel, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemiaMarkus Metzler, Pamela L Strissel, Reiner Strick, et al.
Hemasphere|July 20, 2023
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic LeukemiaDanielle Brandes, Layal Yasin, Karin Nebral, et al.
Pageof 15